Lack of change of lipoprotein(a) levels by the optimization of glycemic control with insulin therapy in NIDDM patients

Diabetes Care

Volumn 20, Issue 9, 1997, Pages 1459-1461

  Caixas̀, Assumpta ^a   Pérez, Antonio ^a,b   Ordóñez Llanos, Jordi ^a   Bonet, Rosa ^a   Rigla, Mercedes ^a   Castellví, Agustina ^a   Bayen L ^a   De Leiva, Alberto ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN A; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; DOSE RESPONSE; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN TREATMENT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT OUTCOME;

EID: 1842376915     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.9.1459     Document Type: Article

References (22)

1. Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 2:120-126, 1979
2. Hoefler G, Harnoncourt F, Kostner GM: Lipoprotein (a): a risk factor for myocardial infarction. Arteriosclerosis 8:398-401, 1988
3. James RW, Boemi M, Sirolla C, Amadio L, Fumelli P, Pometta D: Lipoprotein(a) and vascular disease in diabetic patients. Diabetologia 38:711-714, 1995
4. Ruiz J, Thillet J, Huby T, James RW, Erlich D, Flandre P, Froguel P, Champman J, Passa P: Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients: relationship with apolipoprotein(a) phenotypes. Diabetologia 37:585-591, 1994
5. Velho G, Erlich D, Turpin E, Néel D, Cohen D, Froguel P, Passa P: Lipoprotein(a) in diabetic patients and normoglycemic relatives in familial NIDDM. Diabetes Care 16:744-747, 1993
6. Haffner SM, Morales PA, Stern MP, Gruber MK: Lp(a) concentrations in NIDDM. Diabetes 41:1267-1272, 1992
7. Kuusi T, Yki-Järvinen H, Kauppinen-Mäkelin R, Jauhiainen M, Ehnholm C, Kauppila M, Seppälä P, Viikari J, Kujansuu E, Rajala J, Lahti J, Niskanen L, Marjanen T, Salo S, Ryysy L, Tulokas T, Taskinen R: Effect of insulin treatment on serum lipoprotein (a) in non-insulin-dependent diabetes. Eur J Clin Invest 25:194-200, 1995
8. Chico A, Pérez A, Caixàs A, Ordóñez J, Pou JM, de Leiva A: Lipoprotein(a) concentrations and non-insulin-dependent diabetes mellitus: relationship to glycemic control and diabetic complications. Diabetes Res Clin Pract 33:105-110, 1996
9. Ramirez LC, Arauz-Pacheco C, Lackner C, Albright G, Adams BV, Raskin P: Lipoprotein(a) levels in diabetes mellitus: relationship to metabolic control. Ann Intern Med 117:42-47, 1992
10. Kikuchi T, Onuma T, Shimura M, Tsutsui M, Boku A, Matsui J, Takebe K: Different change in lipoprotein(a) levels from lipid levels of other lipoproteins with improved glycemic control in patients with NIDDM. Diabetes Care 17:1059-1061, 1994
11. Nakata H, Horita K, Eto M: Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications. Metabolism 42:1323-1326, 1993
12. Wolffenbuttel BHR, Leurs PB, Sels JPJE, Rondas-Colbers GJWM, Menheere PPCA, Nieuwenhuijzen AC: Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels. Diabet Med 10:427-430, 1993
13. Rainwater DL, MacCluer JW, Stern MP, VadenBerg JL, Haffner SM: Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes 43: 942-946, 1994
14. O'Brien T, Nguyen TT, Harrison JM, Bailey KR, Dyck PJ, Kottke BA: Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus. Mayo Clin Proc 69:430-435, 1994
15. Heller FR, Jamart J, Honore P, Derue G, Novik V, Galanti L, Parfonry A, Hondekijn JC, Buysschaert M: Serum lipoprotein(a) in patients with diabetes mellitus. Diabetes Care 16:819-823, 1993
16. Scheer WD, Boudreau DA, Cook CB: Lipoprotein(a) levels in African-Americans with NIDDM. Diabetes Care 19:1129-1134, 1996
17. Chang CJ. Kao JT, Wu TJ, Lu FH, Tai TY: Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Diabetes Care 18:1191-1194, 1995
18. Haffner SM, Tuttle KR, Rainwater DL: Lack of change of lipoprotein(a) concentration with improved glycemic control in subjects with type II diabetes. Metabolism 41:116-120, 1992
19. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
20. Hainline A, Karon J, Lippel K (Eds.): Lipid Research Clinic Program. Manual of Laboratory Operations, Lipid and Lipoprotein Analysis. 2nd ed., revised. Washington, DC, U.S. Govt. Printing Office, 1982 (NIH publ. no. 75-628)
21. Haffner SM, Tuttle KR, Rainwater DL: Decrease of lipoprotein (a) with improved glycemic control in IDDM subjects. Diabetes Care 14:302-307, 1991
22. Carreras G, Caixàs A, Llopart R, Ordóñez J, Ferrer I, Chico A, Pérez A: Lp(a) concentrations are not related to glycaemic control in IDDM (Abstract). Diabetes 44 (Suppl. 1):A148, 1995